Lead

In the first half of 2024, four U.S. issuers – CareTrust REIT, Onto Innovation, Hims & Hers Health and a Chubb subsidiary – priced large primary offerings ranging from $350 million to $1.3 billion, providing fresh equity or debt to fund expansion, refinance existing obligations and strengthen balance sheets.

Background

CareTrust REIT (CTRE) is a real‑estate investment trust focused on senior housing and health‑care properties. Onto Innovation (ONTO) designs and manufactures semiconductor test and measurement equipment. Hims & Hers Health (HIMS) operates a telehealth platform offering prescription and over‑the‑counter products. The Chubb subsidiary, identified only as a unit of the global insurer, issues senior unsecured notes to manage its capital structure. All four issuers turned to the public markets in 2024 to raise capital amid a broader environment of elevated interest rates and investor appetite for both equity and convertible debt.

What Happened

CareTrust REIT priced a $509 million upsized common‑stock offering, adding new shares to its capital base. The pricing was reported by both investing.com and Seeking Alpha, confirming the final size after investor demand exceeded the initial target.

Onto Innovation priced a $1.3 billion convertible‑note offering, as detailed by Investing.com. The notes are convertible into Onto’s common stock under specified terms, allowing investors to participate in potential equity upside while providing the company with low‑cost financing.

Hims & Hers Health priced a $350 million senior convertible‑note offering, according to both Investing.com and Seeking Alpha. The notes carry senior status in the capital hierarchy and include conversion features that could turn debt into equity if certain conditions are met.

The Chubb subsidiary priced a $1 billion public offering of 5.30% senior notes due 2036, as reported by Seeking Alpha. The notes are unsecured, senior in ranking, and will mature in 2036, providing the subsidiary with long‑term funding at a fixed coupon.

Market & Industry Implications

These offerings illustrate continued investor demand for both equity and hybrid securities despite a higher‑rate backdrop. CareTrust REIT’s equity raise signals confidence in the senior‑housing sector, which has been navigating demographic shifts and financing constraints. Onto Innovation’s sizable convertible‑note issuance reflects the capital‑intensive nature of semiconductor test equipment and the company’s need to fund R&D and capacity expansion without over‑diluting existing shareholders.

Hims & Hers Health’s senior convertible notes provide a bridge between debt and equity, offering the firm flexibility to convert debt to equity if its stock appreciates, while giving investors downside protection through senior claim status. The Chubb subsidiary’s 5.30% senior notes, priced at a fixed coupon, suggest that insurers’ subsidiaries can still access long‑dated funding at rates that are competitive relative to broader corporate bond markets.

What to Watch

  • Post‑offering stock performance of CareTrust REIT and any subsequent share‑price volatility as the market digests the $509 million equity infusion.
  • Conversion activity on Onto Innovation’s and Hims & Hers Health’s convertible notes, particularly if their underlying stock prices exceed conversion thresholds.
  • Credit rating actions or outlook revisions for the Chubb subsidiary’s senior notes, which could affect secondary‑market pricing and refinancing options.
  • Quarterly earnings releases from each issuer, which will reveal how the newly raised capital is deployed and its impact on revenue growth, profitability and leverage ratios.